(CELH) Celsius Holdings - Overview
Sector: Consumer Defensive | Industry: Beverages - Non-Alcoholic | Exchange: NASDAQ (USA) | Market Cap: 7.447m USD | Total Return: -18.8% in 12m
Industry Rotation: +14.1
Avg Turnover: 266M
Qual. Beats: 0
Rev. Trend: 89.9%
Qual. Beats: 0
Warnings
Beneish M-Score -0.49 > -1.5 - likely earnings manipulation
Below Avwap Earnings
Tailwinds
No distinct edge detected
Celsius Holdings, Inc. (CELH) specializes in the development and global distribution of functional energy drinks and hydration products. Its portfolio includes ready-to-drink beverages and powder sticks marketed under the CELSIUS brand, alongside distribution partnerships for other wellness-focused labels. The company utilizes a multi-channel distribution strategy encompassing major retailers, fitness centers, and e-commerce platforms.
The energy drink sector is characterized by high consumer loyalty and a shift toward clean-label ingredients, such as green tea and ginger, which Celsius integrates into its proprietary formulas. Unlike traditional soft drink companies, functional beverage firms often rely on a hybrid distribution model that combines direct-to-store delivery with independent wholesale networks to maximize shelf presence.
Investors can further examine these market dynamics and financial metrics on ValueRay.
- PepsiCo distribution partnership efficiency drives market share gains and margin expansion
- Inventory rebalancing at major distributors impacts short-term revenue growth projections
- International market penetration scales global sales beyond the core North American segment
- Category competition from incumbent energy brands pressures shelf space and pricing power
- Consumer shift toward functional wellness beverages sustains long-term volume demand trends
| Net Income: 173.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -5.39 > 1.0 |
| NWC/Revenue: 25.72% < 20% (prev 74.75%; Δ -49.03% < -1%) |
| CFO/TA 0.06 > 3% & CFO 329.8m > Net Income 173.7m |
| Net Debt (1.89b) to EBITDA (283.4m): 6.66 < 3 |
| Current Ratio: 1.73 > 1.5 & < 3 |
| Outstanding Shares: last quarter (259.8m) vs 12m ago 9.53% < -2% |
| Gross Margin: 49.62% > 18% (prev 0.50%; Δ 4.91k% > 0.5%) |
| Asset Turnover: 84.61% > 50% (prev 71.48%; Δ 13.13% > 0%) |
| Interest Coverage Ratio: 4.07 > 6 (EBITDA TTM 283.4m / Interest Expense TTM 60.8m) |
| A: 0.15 (Total Current Assets 1.81b - Total Current Liabilities 1.05b) / Total Assets 5.16b |
| B: 0.05 (Retained Earnings 272.0m / Total Assets 5.16b) |
| C: 0.07 (EBIT TTM 247.4m / Avg Total Assets 3.51b) |
| D: 0.07 (Book Value of Equity 273.7m / Total Liabilities 3.91b) |
| Altman-Z'' = 1.69 = BB |
| DSRI: 1.45 (Receivables 832.4m/256.4m, Revenue 2.97b/1.33b) |
| GMI: 1.02 (GM 49.62% / 50.43%) |
| AQI: 3.18 (AQ_t 0.63 / AQ_t-1 0.20) |
| SGI: 2.23 (Revenue 2.97b / 1.33b) |
| TATA: -0.03 (NI 173.7m - CFO 329.8m) / TA 5.16b) |
| Beneish M = -0.49 (Cap -4..+1) = D |
Over the past week, the price has changed by +2.38%, over one month by -9.15%, over three months by -39.66% and over the past year by -18.81%.
- StrongBuy: 8
- Buy: 6
- Hold: 6
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 62 | 108.8% |
P/E Forward = 20.2429
P/S = 2.5085
P/B = 6.1643
P/EG = 0.3119
Revenue TTM = 2.97b USD
EBIT TTM = 247.4m USD
EBITDA TTM = 283.4m USD
Long Term Debt = 668.9m USD (from longTermDebt, last quarter)
Short Term Debt = 7.00m USD (from shortTermDebt, last quarter)
Debt = 2.44b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.89b USD (from netDebt column, last quarter)
Enterprise Value = 9.33b USD (7.45b + Debt 2.44b - CCE 549.2m)
Interest Coverage Ratio = 4.07 (Ebit TTM 247.4m / Interest Expense TTM 60.8m)
EV/FCF = 31.88x (Enterprise Value 9.33b / FCF TTM 292.8m)
FCF Yield = 3.14% (FCF TTM 292.8m / Enterprise Value 9.33b)
FCF Margin = 9.86% (FCF TTM 292.8m / Revenue TTM 2.97b)
Net Margin = 5.85% (Net Income TTM 173.7m / Revenue TTM 2.97b)
Gross Margin = 49.62% ((Revenue TTM 2.97b - Cost of Revenue TTM 1.50b) / Revenue TTM)
Gross Margin QoQ = 48.31% (prev 47.37%)
Tobins Q-Ratio = 1.81 (Enterprise Value 9.33b / Total Assets 5.16b)
Interest Expense / Debt = 0.49% (Interest Expense 11.8m / Debt 2.44b)
Taxrate = 19.95% (27.4m / 137.5m)
NOPAT = 198.1m (EBIT 247.4m * (1 - 19.95%))
Current Ratio = 1.73 (Total Current Assets 1.81b / Total Current Liabilities 1.05b)
Debt / Equity = 1.95 (Debt 2.44b / totalStockholderEquity, last quarter 1.25b)
Debt / EBITDA = 6.66 (Net Debt 1.89b / EBITDA 283.4m)
Debt / FCF = 6.44 (Net Debt 1.89b / FCF TTM 292.8m)
Total Stockholder Equity = 2.31b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.95% (Net Income 173.7m / Total Assets 5.16b)
RoE = 7.51% (Net Income TTM 173.7m / Total Stockholder Equity 2.31b)
RoCE = 8.30% (EBIT 247.4m / Capital Employed (Equity 2.31b + L.T.Debt 668.9m))
RoIC = 9.95% (NOPAT 198.1m / Invested Capital 1.99b)
WACC = 7.80% (E(7.45b)/V(9.88b) * Re(10.22%) + D(2.44b)/V(9.88b) * Rd(0.49%) * (1-Tc(0.20)))
Discount Rate = 10.22% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 26.26 | Cagr: 5.19%
[DCF] Terminal Value 82.25% ; FCFF base≈258.0m ; Y1≈318.3m ; Y5≈543.0m
[DCF] Fair Price = 30.71 (EV 9.74b - Net Debt 1.89b = Equity 7.85b / Shares 255.6m; r=7.80% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.16 | # QB: 0
Revenue Correlation: 89.91 | Revenue CAGR: 38.68% | SUE: 0.32 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.43 | Chg30d=-7.47% | Revisions=-47% | Analysts=17
EPS next Quarter (2026-09-30): EPS=0.44 | Chg30d=-10.40% | Revisions=-70% | Analysts=17
EPS current Year (2026-12-31): EPS=1.63 | Chg30d=+0.62% | Revisions=+10% | GrowthEPS=+21.5% | GrowthRev=+33.1%
EPS next Year (2027-12-31): EPS=2.04 | Chg30d=+0.40% | Revisions=+5% | GrowthEPS=+25.3% | GrowthRev=+9.8%
[Analyst] Revisions Ratio: -70%